STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #638 by analyst upside · 2026-06-27
ANNX
Annexon, Inc.
Healthcare · Market Cap $898M · P/E 0x
ANALYST PRICE TARGET
+139.5%
implied upside to consensus target
Current Price $5.48
Consensus Target $13.12
Bull Target $27.0
Bear Target $7.0
Analysts Covering 8
ANALYST CONSENSUS — BUY
Strong Buy
2
Buy
6
Hold
0
Sell
0
52-Week Low $1.85
52-Week High $7.18
YTD Return +16.8%
FUNDAMENTALS
Market Cap $898M
P/E Ratio (TTM) N/A
Forward P/E -5.9x
EPS (TTM) $-1.20
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.85
52-Week High $7.18
Current Price $5.48
Bear Target $7.0
Bull Target $27.0
● Now $5.48 ● Target $13.12
TRADING DATA
Avg Volume 2.6M
YTD Return +16.8%
Analyst Count 8
Consensus Buy
Upside to Target +139.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Annexon, Inc. (ANNX) is currently trading at $5.48 with a Wall Street consensus price target of $13.12, implying potential upside of 139.5% over the next 12 months. 8 analysts currently cover ANNX, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $27.0, while the most cautious has a target of $7.0.

ANNX operates in the Healthcare sector with a market capitalisation of $898M. The stock is up 16.8% year-to-date and is currently trading near the upper end of its 52-week range of $1.85 – $7.18.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ANNX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs ● Initiated
Neutral 2026-05-12 Building track record
Chardan Capital — Reiterated
Buy → Buy 2026-03-20 33% win rate (6 calls)
Chardan Capital ● Initiated
Buy 2025-12-23 33% win rate (6 calls)
Clear Street ● Initiated
Buy 2025-12-02 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2025-11-19 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-08-15 31% win rate (48 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-05-14 31% win rate (48 calls)
Needham — Reiterated
Buy → Buy 2025-05-13 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →